Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1034-1042

  Plum, J ^a   Mirzaian, Y ^a   Grabensee, B ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Atrial natriuretic peptide; Natriuresis; Nephrotic syndrome; Proteinuria; Renal haemodynamics

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR ALPHA; CYCLIC GMP; IMMUNOGLOBULIN G; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EDEMA; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; MALE; NATRIURESIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SECOND MESSENGER; SODIUM EXCRETION; SODIUM RETENTION; URINE LEVEL;

EID: 0029943683     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.6.1034     Document Type: Article

References (28)

1. Brown EA, Markandu N, Sagnella GA, Jones BE, MacGregor GA. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission. Nephron 1985; 39: 290-295
2. Geers AB, Koomans HA, Roos JC, Boer P, Dorhout Mees EJ. Functional relationships in the nephrotic syndrome. Kidney Int 1984; 26: 324-330
3. Perico N, Delaini F, Lupini C, Remuzzi G. Renal response to atrial peptides is reduced in experimental nephrosis. Am J Physiol 1987; 252: F654-F660
4. Peterson C, Madsen B, Perlman A, Chan AYM, Meyers BD. Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans. Kidney Int 1988; 34: 825-831
5. Valentin JP, Qui C, Muldowney WP, Ying WZ, Gardner DG, Humphreys MH. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 1992; 90: 1302-1312
6. Pedersen B, Danielsen H, Eiskjaer H, Jespersen B, Sorensen SS. Increased atrial natriuretic peptide in the nephrotic syndrome. Relationship to the renal function and the renin-angiotensin-aldosterone system. Scand J Clin Lab Invest 1988; 48: 141-147
7. Ishii M, Hirata Y, Sugimoto T, Matsuoka H, Kimura K, Ischimitsu T et al. Effect of alpha human atrial natriuretic peptide on proteinuria in patients with primary glomerular diseases. Clin Sci 1989; 77: 643-650
8. Zietse R, Schalekamp MA. Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome. Kidney Int 1988; 34: 717-724
9. Rodriguez-Iturbe B, Colic D, Parra G, Gutkowska J. Atrial natriuretic factor in the acute nephritic and nephrotic syndromes. Kidney Int 1990; 38: 512-517
10. Dohout M, Geers AB, Koomans S. Blood volume and sodium retention in the nephrotic syndrome: a controversial pathophysiological concept. Nephron 1984; 36: 201-211
11. McMurray J, Seidelin PH, Howey JE, Balfour DJ, Struthers AD. The effect of atrial natriuretic factor on urinary albumin and beta-2-microglobulin excretion in man. J Hypertens 1988; 6: 783-786
12. Busse MW, Zisowsky S, Henschen S, Panning B, Reilmann L. Determination of circulating blood volume by measurement of indocyanine green dye in hemolysate: a preliminary study. Life Sci 1990; 46: 647-652
13. Haller M, Brechteisbauer H, Finsterer U et al. Bestimmung des Plasmavolumens mit Indocyaningrün beim Menschen. Anaesthesist 1992; 41: 115-120
14. Smith HW. The kidney: Structure and Function in Health and Disease, Oxford University Press, London, 1951
15. Reubi FC, Gossweiler N, Gürtler R, Huber A. Methods of measuring renal circulation in man. In: Proceedings of the 2nd International Congress of Nephrology. Excerpta Medica, Amsterdam: 78, 1964
16. Boulier A, Fricker J, Thomasset AL, Apfelbaum M. Fat-free mass estimation by the two-electrode impedance method. Am J Clin Nutr 1990; 52: 581-585
17. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73/1: 13-22
18. Hamet P, Tremblay J, Pang SC. Cyclic GMP as mediator and biological marker of atrial natriuretic factor. J Hypertens 1986; 4[Suppl. 2]: 49-56
19. Murad F, Leitman DC, Bennett BM, Molina C, Waldman SA. Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation. Am J Med Sci 1987; 294(3): 139-143
20. Wong KR, Xie MH, Shi LB et al. Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor. Am J Physiol 1988; (Renal Fluid Electrolyte Physiol) 255/6 (24/6): 1220-1224
21. Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. J Clin Endocrinol Metab 1987; 65/4: 765-772
22. Mizelle HL, Hall JE, Hildebrandt DA. Atrial natriuretic peptide and pressure natriuresis: interactions with the renin-angiotensin system. Am J Physiol 1989; (Regul Integr Comp Physiol) 257/5 (26/5): 1169-1174
23. Weidmann P, Hasler L, Gnädinger MPP et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734-742
24. Richards AM, McDonald D, Fitzpatrick MA et al. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988; 67: 1134-1139
25. Venkatachalam MA, Rennke HG. The structural and molecular basis of glomerular filtration. Circ Res 1978; 43: 337-347
26. Mayer G, Lafayette RA, Oliver J, Deen WM, Myers BD, Meyer TW. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Kidney Int 1993; 43/2: 346-353
27. Hirata Y, Ishii M, Fukui K et al. Effects of atrial natriuretic peptide on urinary protein excretion in mesangial proliferative glomerulonephritis. Nephron 1991; 58: 58-61
28. Plum J, Mirzaian Y, Grabensee B. Influence of ANP on natriuresis, albuminuria and glomerular permeability in the nephrotic syndrome. JASN 1994; 5 (3): 358